Innospec Inc.

I'm InnoSpec's General Counsel and Chief Compliance Officer. The earnings released for the quarter and this presentation are posted on the company's website. During this call, we will make forward-looking statements, which are predictions about future events. These statements are based on current expectations and assumptions that are subject to risk and uncertainties that could cause actual results to differ from the anticipated results implied by such forward-looking statements. These risks and uncertainties are detailed in InnoSpec's 10-K, 10-Qs, and other filings with the SEC. Please see the SEC site and Inspec site for these and related documents. In today's presentation, we have also included non-GAAP financial measures. A reconciliation to the most directly comparable GAAP financial measure is contained in the earnings release. The non-GAAP financial measure should not be considered as a substitute for or superior to those prepared in accordance with that. They are included to aid investor understanding of the company's performance in addition to the impact these items and events had on financial results. With me today from Innspec are Patrick Williams, President and Chief Executive Officer, and Ian Clemmensen, Executive Vice President and Chief Financial Officer. And with that, I turn it over to you, Patrick.

Thank you, David, and welcome everyone to Innspec's third quarter 2025 conference call. This was a mixed quarter for Innspec with continued strong operating income growth and margin expansion in fuel specities, offsetting lower results in performance chemicals and oilfield services. Performance Chemicals continued to deliver sales growth over the prior year, where gross margins declined as expected on higher cost, price management, and weaker product mix. These combined factors drove results below our expectations, but we are executing on multiple top-line cost and other margin improvement opportunities identified in the business. Late the third quarter, we began to see a positive impact from our initial actions and we're optimistic that we will deliver sequential operating income and margin improvement in the fourth quarter. Over the medium term, we have a strong pipeline of margin accretive opportunities across all our end markets, and we are working to accelerate these actions. Hill Specialties had another strong quarter with double-digit operating income growth and improved margins. Margins continue to track at the upper end of our expected range, and our outlook is for steady performance in the fourth quarter. Oilfield services operating income declined sequentially and versus the prior year on lower than anticipated Middle East activity due to customer timing and phasing. We are optimistic that we will deliver sequential operating income and margin improvement in the fourth quarter as Middle East activity returns and our new DRA expansion comes online. We remain focused on margin improvement in all segments. Our outlook does not assume any resumption of Mexico sales. Now I will turn the call over to Ian Clementson, who will review our financial results in more detail. Then I will return with some concluding comments. After that, Ian and I will take your questions. Ian? Thanks, Patrick.

Turning to slide seven in the presentation, the company's total revenues for the third quarter were $441.9 million. similar to the $443.4 million reported a year ago. Overall gross margin decreased by 1.6 percentage points from last year to 26.4%. Adjusted EBITDA for the quarter was $44.2 million compared to $50.5 million last year, and net income for the quarter was $12.9 million compared to $33.4 million a year ago. Our gap earnings per share were 52 cents compared to $1.33 recorded last year. Our headline results for the quarter include 24.4 million in charges which had a negative EPS impact of 57 cents. These charges are composed of 42.9 million of assets and intangible impairments and restructuring charges related to the expected lack of near-term recovery in our QGP business in Brazil, our Mexican oilfield production business, and our US oilfield stimulation business. These charges were offset by an 18.5 million reduction to the fair value of contingent consideration associated with the 2023 acquisition of QGP. Excluding these and other special items in both years, our adjusted EPS for the quarter was $1.12 compared to $1.35 a year ago. Turning to slide 8, revenues in performance chemicals for the third quarter were $170.8 million, up 4% from last year's $163.6 million. Volumes fell by 2%, offset by a positive price mix of 3% and favourable currency impact of 3%. Gross margin of 15.1% decreased seven percentage points compared to 22.1% in the same quarter in 2024 due to higher costs, price management, and weaker product mix. Operating income of 9.2 million decreased 54% from 20 million last year. Moving on to slide nine, revenues in fuel specialties for the third quarter were 172 million, up 4% from the 165.8 million reported a year ago. Volumes were down 7% with price mix up 7% and a positive currency impact of 4%. Fuel Specialty's gross margins of 35.6% were up two percentage points above the same quarter last year, benefiting from a stronger sales mix and disciplined pricing. Operating income of 35.3 million was up 14% from 30.9 million a year ago. Moving on to slide 10, revenues in oilfield services for the quarter were 99.1 million, down 13% from 114 million in the third quarter last year. Gross margins of 30% increased 1.7 percentage points from last year's 28.3% due to a better sales mix. Operating income of 4.8 million decreased 32% from 7.1 million a year ago. Turning to slide 11, corporate costs for the quarter were 18.2 million compared with 11.8 million a year ago, which included an 8.4 million recovery of historic pension costs. The adjusted effective tax rate for the quarter was 22.5% compared to 24.6% in the same period last year due to the geographical mix of taxable profits. We expect the full year adjusted tax rate to be around 25%. Moving on to slide 12, cash flow from operating activities was 39.3 million before capital expenditures of 22.2 million. In the third quarter, we bought back almost 123,000 shares at a cost of 10.7 million. As of September 30th, Interspec had 270.8 million in cash and cash equivalents and no debt. And now I'll turn it back over to Patrick for some final comments.

Thanks, Ian. We continue to prioritize gross margin and operating income actions in performance chemicals and oilfield services, and we expect to deliver sequential growth in the fourth quarter. We remain focused on a combination of sales, price-cost actions, new technology, commercialization, and other opportunities to drive sustainable improvement. In addition, we expect fuel subsidies to continue to deliver strong results. Operating cash generation was again positive in the fourth quarter, and our net cap position closed at over $270 million. We have significant balance sheet flexibility for M&A, dividend growth, organic investment, and buybacks. This quarter, our board approved a further 10% increase in our semi-annual dividend to 87 cents per share, And we continued our record of returning value to shareholders with $10.7 million in share repurchases. Now I'll turn the call over to the operator, and he and I will take your questions.

Thank you. To ask a question, you will need to press star 1 and 1 on your telephone and wait for your name to be announced. To withdraw your question, please press star 1 and 1 again. We will now go to your first question. And your first question today comes from the line of Mike Harrison from Seaport Research Partners. Please go ahead.

Hi, good morning. Good morning, Mike. I wanted to start with a couple questions on the performance chemicals business. I was hoping to start that you could give us a little more color on what's going on with the gross margin there, a couple hundred basis points of sequential production. decline there. Did the oleochemicals raw material headwind get incrementally worse this quarter? Did mix get worse sequentially? Were there other factors? And I was hoping you could also address what you mean by price management as one of the issues impacting margin in performance chemicals.

Yeah, let me take that first, Mike, and Patrick will come over to talk with some comments. What we saw in July and August was the continuing headwinds from the oleochemicals. That's put pressure on our pricing and our mass-through ability. I think what's important is that as we've moved through September and into October, the actions that we talked about on the last call have started to take effect. We've seen the business improve from the gross margin perspective and And we're expecting the Q4 gross margin to be much closer to 18%. So that's up a full three percentage points sequentially Q3 to Q4. Also, I think it's worth remembering that in Q3, we do have a slower period in July and August, particularly in Europe with the shutdowns and the holiday season. So it's always a little bit weaker. I think the important thing is that our demand remains really strong. Volumes remain good. We've got a lot of work that we need to do internally. We've done some of that. We've got more to do. The team are on it, and we're starting to see the positive impacts of that coming through.

Yeah, Mike, we talked about it in the previous quarter, actually previous two-quarter calls, that we had a lot of actions that we had to take to manage margins better than we have in the past. And as Ian alluded to, all these actions have really come forth right. We've really done a good job in the last month of this quarter, and we're starting to see even better going into Q4. So the actions the guys have put in place, whether it's pricing, manufacturing efficiencies, new product, product mix, raw materials, it's just being managed better than it has. I think we've learned a few lessons along the way, and we should see those improving as we go forward.

All right, and then can you specifically talk about what are some of the commercial actions you're looking at in performance chemicals? I think you referenced some top-line opportunities maybe across multiple different end markets. Can we just get a little more detail there?

Yeah, I mean, we continuously, you know, have a lot of products run through our disruptive technology group that we introduced to the market. There was a little lull over probably the last year hence why our product mix was off a little bit. But we are introducing new products to the market probably this quarter and throughout next year, which will help with the balance. So it's more, and it's technology might cross all sectors, whether it's agriculture, mining, personal care, it's really all sectors that we have new product technologies coming through. There was a general low in the market because instead of looking at, you know, the big trends were 1,4-dioxane-free, sulfate-free, 1-nitrosamine-free, That market is now stabilized out and other competitors have jumped in. We're now looking at what's the new move on the horizon. And these are products that we should be introducing over the next three to six months.

All right. Very helpful.

And then in the fuel specialties business, seasonally you would typically see better margin performance. as you start to get some cold flow improvers and the mix just kind of shifts seasonally. It sounded to me like you're saying you expect that business to be more steady in terms of earnings from Q3 into Q4. So I was just hoping that you could address whether we should see that normal seasonal pickup or if something else is going on.

Yeah, Mike, we've had a really good year in fuel specialties. The business has executed extremely well on pricing, on top-line initiatives, and we've seen the benefit of that coming through in a very strong gross margin performance. As you remember, in Q2, the gross margins were 38%. In Q3, they're at 35%. We expect that 35% to be about the same in Q4, maybe a little bit up, maybe a little bit down, but certainly around that mark. And that's really a function of where the pricing and the timing of that pricing works. As you know, there's a lag up and down. We're seeing a pretty stable environment in terms of raw materials there right now. And as you're right, we'll start to see a pickup in those winter businesses. And we're going to hit round about that $35 million of operating income in Q4. And we feel pretty good about that.

That'll top off an extremely strong year for fuel specialties.

And maybe just to ask a little bit more broadly on the outlook, it sounds like you expect sequential improvement in performance chemicals as well as oil field services and then maybe flattish in fuel specialties. So is the expectation that EPS gets into the, I don't know, 120, 130 range? It doesn't seem like maybe you have enough tailwind to get – up to that 140-ish level that you were at last year?

No, we won't be up at 140, Mike. We'll be above $1. You said sort of that 120 to 125 range. I think as we sit here right now, we'd be disappointed not to get there. We feel comfortable about October. November's looking good. December, as you can imagine, with year-end customer actions, weather, it can be a little bit variable for us.

But that's certainly the range that we're aiming for.

All right. Thanks very much. Thanks, Mark. Thanks, Mark.

Thank you. We will now take the next question. And the question comes from the line of John Tamanteng from CGS. Please go ahead.

Hi. Good morning, and thank you for taking my questions. I was wondering if you could touch a little bit more on the timing. Good morning. If you could touch more on the timing in the oil field business as it pertains to Middle East clients and how that runs through in Q4. Is your expectation for the second half the same as it was previously and it just catches up in Q4 or does everything just push out to the right maybe because there's not enough time to catch up to what was happening?

Yeah, there's not enough time to catch up. We saw activity starting to pick back up in Q4. It's just timing. There's no loss of customers. It's just timing with the customers. It's all Middle East.

To the right as opposed to a catch-up occurring in Q4. Correct. Correct. Okay. Understood. And then in Q3, could you just give a little bit more detail as to what drove the underperformance in performance chemicals? And then as you go into the Q4, we're expecting the pricing to catch up, which is what I think you've been saying all along. Will it catch up to the degree you had previously expected or not? Is there more of a headwind there now incrementally in Q4 compared to what you expected before?

Yeah, there were a lot of issues. We talked about the last quarter, and those issues remained. I mean, it was pricing issues to the customer. It was raw material actions, spike in raw materials. It was a lag in contracts up or down. At this point, we got caught on the downside. It was flexibility of assets. It was product mix. It was the introduction of new technologies, which we'll start seeing in Q4. It was manufacturing efficiencies. There were a lot of things. You know, we had a big spike in growth, and sometimes you forget about the internal issues you have to manage. And so, all the actions have been in place, and as Ian alluded to, the last month of this quarter showed a very strong quarter, or a very strong month, I should say, and we should have some nice momentum going into Q4.

Okay, great. Can you speak to the momentum you expect heading into Q1 of next year in that business as you fix all these things and maybe speak a little bit to the underlying customer demand you expect?

Yeah, customer demand is strong. We've had no issue with customer demand at all. It's quite frankly, it's just all the things that we just talked about that we had to get internally fixed and obviously the contracts had to catch up too on pricing. You know, you've had pricing catch up, and then all of a sudden raw materials spike again, and you're now another three months delay. And so you get the benefit on the downside, but on the upside, it hurts you a little bit. But, you know, I think for all of us, we're seeing a lot more stability going into Q4, and it should really carry over to Q1 next year.

Understood. Thanks. And then lastly, could you just speak to capital allocation? It looks like you bought back some shares. It looks like your stock price might be giving you opportunities here. I'm just wondering if you're more biased there or you're saving your firepower for M&A or other activities?

It's still a nice balance. I think you're right. At this share price, we're still buying back. You saw that we also increased our dividend. I think that we are seeing some stressed assets out there, so we want to have some dry powder. Obviously, we have to have our internal house managed appropriately as we are going into Q4. But I think for next year, we do want to have dry powder. We are going to continue to buy back at this price. And we are going to continue to increase our dividend. And we've done, I think, a very good job on all ends. But having the dry powder will be key moving into next year. Got it.

Thank you, guys. Thanks, John. Thanks, John.

Thank you. That concludes the Q&A session. I will now hand the call back to Patrick Williams for closing remarks.

Thank you all for joining us today, and thanks to all our shareholders, customers, and InnoSpec employees for your interest and support. If you have any further questions about InnoSpec or matters discussed today, please give us a call. We look forward to meeting up with you again to discuss our fourth quarter 2025 results in February. Have a great day.

Thank you. This concludes today's conference call. Thank you for participating. You may now disconnect.